
A weekly publication by the Bureau of Epidemiology
March 2, 2001"The reason for collecting, analyzing and disseminating information on a disease is to control that disease. Collection and analysis should not be allowed to consume resources if action does not follow."
--Foege WH et al. Int. J of Epidemiology 1976; 5:29-37.
Richard S. Hopkins, MD, MSPH, Bureau Chief, State Epidemiologist
Don Ward, Surveillance Section Administrator, Epi Update Managing Editor
Jason Glisson, BS, Epi Editorial Assistant
Bureau of Epidemiology Frequent Contributors:
|
Steven Wiersma, MD, MPH, Deputy State Epidemiologist |
Jodi Baldy, MPH, Biological Scientist IV |
|
Ursula E. Bauer, PhD, Chronic Disease Epidemiologist |
Lisa Conti, DVM, MPH, State Public Health Veterinarian |
Regional Epidemiologists:
|
Dolly Katz, PhD, MPH, SE Florida |
Roger Sanderson, RN, MA, SW Florida |
Carina Blackmore, MS Vet. Med., PhD, NE Florida Carina Blackmore, MS Vet. Med., PhD, |
Zuber Mulla, MSPH, Central Florida Carina Blackmore, MS Vet. Med., PhD, |
Please print out this material and share with epidemiology staff, county health department directors, administrators, medical directors, nursing directors, environmental health directors and others with an interest in information of this type. Thank you.
The Bureau of Epidemiology is available 24 hours a day, 7 days a week for consultation at our main number (SunCom 205-4401 or 850/245-4401) PLEASE NOTE: Consultation after 5 p.m. & on weekends is intended for emergencies.
The Department of Health has a home on the World Wide Web at
http://www.doh.state.fl.usIn this issue:
1. National Infant Immunization Week
2. Influenza Surveillance Update
1. National Infant Immunization Week
Henry T. Janowski, MPH, Chief, Bureau of Immunization
April 22-28, 2001 has been designated National Infant Immunization Week and, again, the Bureau of Immunization is calling upon all health care providers to assist in spreading the immunization message. Since the private medical community administers two out of every three immunizations in Florida, reaching out to these providers is an essential element of our campaign.
In 2000, Florida’s immunization coverage level for two-year-olds rose to an all-time high of 86.6 percent. National Infant Immunization Week offers an excellent opportunity for us to celebrate our successes and to reaffirm our commitment to preventive child health care through immunizations. Please work with us by:
Incorporating the immunization message into an organization-wide presentation, newsletter, or other mode of communication.
Emphasizing the importance of adhering to the Recommended Childhood Immunization Schedule-a practice that not only prevents the spread of vaccine-preventable disease, but also serves as a vehicle to bring children into a "medical home" for routine preventative health care. (A copy of the schedule can be found on the Centers for Disease Control and Prevention’s (CDC) Web site at http://www.cdc.gov/nip/recs/child-schedule.PDF
Encourage implementation of the Standards of Pediatric Immunization Practices (see attached).
If you have any questions regarding the campaign, please contact Linda Zeigler, Bureau of Immunization, at (850) 245-4342 or SunCom 205-4342.
2. Influenza Surveillance Update
Carina Blackmore, MS, Vet. Med., PhD, NE Florida
(Week ending February 17, 2001-Week 7)
Florida: Florida is one of 14 states still reporting low levels of influenza activity. Overall, two percent of 14,085 patients seeking care by reporting physicians in the influenza sentinel surveillance met the case definition for ILI during week 7. Two isolates of influenza were reported to our laboratory database this week: influenza B was reported from Duval and Franklin counties. Since October 1, of 2000,118 influenza isolations have been reported to the state health office: 40 influenza A (H1N1) isolates from Broward, Charlotte, Dade, Duval, Escambia, Hillsborough, Indian River, Lake, Leon, Nassau, Orange and Polk counties, one influenza A (H3N2) from Duval county, 16 untyped influenza A isolates from Alachua, Clay, Columbia, Hillsborough, Orange, Palm Beach and Pinellas counties) and 61 influenza B isolates from Brevard, Broward, Charlotte, Clay, Duval, Franklin, Hillsborough, Indian River, Leon, Levy, Orange, Palm Beach, Santa Rosa, Seminole and Volusia counties.
National report: Influenza activity appears to be declining in the United States. For the current season, the overall national percentage of respiratory specimens positive for influenza appears to have peaked at 24% at the end of January (week 4). During the past 3 seasons, the peak percentages of respiratory specimens positive for influenza viruses have ranged from 28% to 33%. For this season, the percentage of patient visits to sentinel physicians for ILI appears to have peaked at 4% in the mid to late January (weeks 3-5). During the past 3 seasons, the peak percentages for such visits ranged between 5% and 6%. During week 7, 7 states (Colorado, New Jersey, North Carolina, Oklahoma, Rhode Island, Tennessee, and Utah) state and territorial health departments reported widespread and 27 states reported regional activity during week 7. Fifteen percent of the 1,595 specimens tested in WHO and NREVSS laboratories reported 1,459 were positive for influenza. A majority of these isolates (52%) were influenza type B. The highest yield in recent weeks (weeks 5-7) was seen in from patients in the New England region where 34% tested positive for flu.
The 2000-2001 flu vaccine induces reactive antibodies against all 389-virus strains that have been antigenically characterized at CDC this year.
During week 7, the percentage of all deaths due to P&I as reported by the vital statistics offices of 122 U.S. cities was 7.8%, which is below the epidemic threshold of 8.7%
Three percent of patient visits to U.S. sentinel physicians were due to influenza-like illness (ILI). The percentage of patient visits for ILI was within baseline levels (3%) in 8 of 9 surveillance regions. Influenza activity was above baseline levels (4%) in the Pacific Region.
Between 23.2% and 35.2% of tested specimens were positive for Respiratory Syncytial Virus (RSV) this week. Twelve Florida hospital laboratories participate in this program
.
3. Weekly Disease Table (Week 8)
| DISEASE |
1998 TO |
1999 TO |
2000 TO |
3 YEAR |
2000 |
2001 TO |
|
Animal Rabies |
34 |
24 |
17 |
25 |
161 |
25 |
|
Anthrax |
0 |
0 |
0 |
0 |
0 |
0 |
|
Botulism, foodborne |
0 |
0 |
0 |
0 |
0 |
0 |
|
Botulism, infant |
0 |
0 |
0 |
0 |
0 |
0 |
|
Botulism, wound |
0 |
0 |
0 |
0 |
0 |
0 |
|
Botulism, other |
0 |
0 |
0 |
0 |
0 |
0 |
|
Brucellosis |
0 |
0 |
0 |
0 |
2 |
0 |
|
Campylobacteriosis |
69 |
76 |
69 |
71.3333 |
1024 |
57 |
|
Ciguatera |
0 |
0 |
0 |
0 |
14 |
0 |
|
Cryptosporidiosis |
12 |
3 |
8 |
7.6667 |
178 |
12 |
|
Cyclosporiasis |
0 |
0 |
0 |
0 |
9 |
18 |
|
Dengue Fever |
0 |
1 |
0 |
0.3333 |
5 |
1 |
|
Diphtheria |
0 |
0 |
0 |
0 |
0 |
0 |
|
Ehrlichiosis, human |
0 |
0 |
0 |
0 |
1 |
0 |
|
Encephalitis, chickenpox |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, Eastern Equine |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, herpes |
3 |
0 |
0 |
1 |
6 |
0 |
|
Encephalitis, influenza |
0 |
0 |
0 |
0 |
1 |
0 |
|
Encephalitis, measles |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, mumps |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, other |
0 |
1 |
0 |
0.3333 |
8 |
0 |
|
Encephalitis, St. Louis |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, Venezuelan |
0 |
0 |
0 |
0 |
0 |
0 |
|
Encephalitis, Western Equine |
0 |
0 |
0 |
0 |
0 |
0 |
|
Escherichia Coli 0157:H7 |
2 |
3 |
3 |
2.6667 |
95 |
2 |
|
Escherichia Coli, other |
0 |
1 |
2 |
1 |
14 |
1 |
|
Giardiasis |
119 |
97 |
68 |
94.6667 |
1433 |
60 |
|
H. Influenzae Cellulitis |
1 |
0 |
0 |
0.3333 |
1 |
0 |
|
H. Influenzae Epiglottitis |
0 |
0 |
0 |
0 |
1 |
0 |
|
H. Influenzae Meningitis |
3 |
2 |
0 |
1.6667 |
12 |
2 |
|
H. Influenzae Pneumonia |
1 |
1 |
0 |
0.6667 |
8 |
6 |
|
H. Influenzae Prim.Bacteremia |
6 |
2 |
3 |
3.6667 |
55 |
12 |
|
H. Influenzae Septic Arthritis |
0 |
0 |
0 |
0 |
1 |
0 |
|
Hantaviris Infection |
0 |
0 |
0 |
0 |
0 |
0 |
|
Hemolytic Uremic Syndrome |
0 |
0 |
1 |
0.3333 |
16 |
0 |
|
Hemorrhagic Fever |
0 |
0 |
0 |
0 |
0 |
0 |
|
Hepatitis A |
69 |
55 |
50 |
58 |
589 |
61 |
|
Hepatitis B |
26 |
24 |
34 |
28 |
508 |
29 |
|
Hepatitis B (+HbsAg in pregnant women) |
NR |
3 |
19 |
NR |
475 |
17 |
|
Hepatitis, Perinatal Hep B |
NR |
0 |
0 |
NR |
1 |
0 |
|
Hepatitis C |
NR |
2 |
2 |
NR |
21 |
1 |
|
Hepatitis, Non-A, Non-B |
7 |
0 |
1 |
2.6667 |
6 |
0 |
|
Hepatitis, Other, including unspecified |
0 |
1 |
2 |
1 |
7 |
0 |
|
Lead Poisoning |
214 |
187 |
72 |
157.6667 |
944 |
52 |
|
Legionellosis |
8 |
5 |
7 |
6.6667 |
53 |
4 |
|
Leprosy |
1 |
0 |
0 |
0.3333 |
4 |
0 |
|
Leptospirosis |
0 |
0 |
0 |
0 |
2 |
0 |
|
Listeriosis |
NR |
2 |
2 |
NR |
32 |
2 |
|
Lyme Disease |
1 |
1 |
0 |
0.6667 |
52 |
0 |
|
Malaria |
4 |
9 |
4 |
5.6667 |
86 |
3 |
|
Measles |
1 |
0 |
0 |
0.3333 |
2 |
0 |
|
Meningitis, Group B Strep |
1 |
2 |
0 |
1 |
21 |
2 |
|
Meningitis, List Monocytogenes |
1 |
0 |
1 |
0.6667 |
7 |
0 |
|
Meningitis, Meningococcal |
9 |
6 |
6 |
7 |
42 |
10 |
|
Meningitis, other |
7 |
4 |
5 |
5.3333 |
108 |
4 |
|
Meningitis, Strep Pneumoniae |
20 |
17 |
19 |
18.6667 |
111 |
12 |
|
Meningococcemia, disseminated |
12 |
8 |
15 |
11.6667 |
82 |
10 |
|
Mercury Poisoning |
0 |
0 |
1 |
0.3333 |
11 |
0 |
|
Mumps |
2 |
0 |
0 |
0.6667 |
4 |
0 |
|
Neurotoxic Shellfish Poisoning |
0 |
0 |
0 |
0 |
0 |
0 |
|
Pertussis |
8 |
3 |
1 |
4 |
48 |
1 |
|
Plague, Bubonic |
0 |
0 |
0 |
0 |
0 |
0 |
|
Plague, Pneumonic |
0 |
0 |
0 |
0 |
0 |
0 |
|
Poliomyelitis |
0 |
0 |
0 |
0 |
0 |
0 |
|
Psittacosis |
0 |
0 |
0 |
0 |
3 |
0 |
|
Q Fever |
NR |
0 |
0 |
NR |
0 |
0 |
|
Human Rabies |
0 |
0 |
0 |
0 |
0 |
0 |
|
Rocky Mountain Spotted Fever |
0 |
0 |
0 |
0 |
1 |
0 |
|
Rubella |
0 |
0 |
0 |
0 |
2 |
0 |
|
Rubella, Congenital |
0 |
0 |
0 |
0 |
1 |
0 |
|
Salmonellosis |
164 |
178 |
139 |
160.3333 |
2742 |
152 |
|
Shigellosis |
125 |
134 |
111 |
123.3333 |
1283 |
63 |
|
Smallpox |
NR |
0 |
0 |
NR |
0 |
0 |
|
Staphylococcus Aureus (GISA/VISA) |
NR |
0 |
0 |
NR |
0 |
0 |
|
Staphylococcus Aureus (GRSA/VRSA) |
NR |
0 |
0 |
NR |
0 |
0 |
|
Streptococcal Disease, Invasive Group A |
4 |
8 |
12 |
8 |
147 |
19 |
|
Streptococcus Pneumoniae, Invasive |
86 |
52 |
155 |
97.6667 |
1138 |
147 |
|
Tetanus |
0 |
0 |
0 |
0 |
1 |
0 |
|
Toxoplasmosis |
3 |
0 |
0 |
1 |
12 |
0 |
|
Trichinosis |
0 |
0 |
0 |
0 |
1 |
0 |
|
Tularemia |
NR |
0 |
0 |
NR |
0 |
0 |
|
Typhoid Fever |
4 |
4 |
0 |
2.6667 |
12 |
1 |
|
Vibrio Alginolyticus |
0 |
2 |
1 |
1 |
15 |
0 |
|
Vibrio Cholerae Type 01 |
0 |
0 |
0 |
0 |
0 |
0 |
|
Vibrio Cholerae Non-01 |
0 |
2 |
1 |
1 |
4 |
0 |
|
Vibrio Fluvialis |
0 |
0 |
0 |
0 |
2 |
0 |
|
Vibrio Hollisae |
0 |
0 |
1 |
0.3333 |
3 |
0 |
|
Vibrio Mimicus |
0 |
0 |
0 |
0 |
2 |
0 |
|
Vibrio, other |
0 |
0 |
0 |
0 |
1 |
0 |
|
Vibrio Parahaemolyticus |
0 |
1 |
1 |
0.6667 |
16 |
0 |
|
Vibrio Vulnificus |
0 |
1 |
0 |
0.3333 |
13 |
0 |
|
Yellow Fever |
0 |
0 |
0 |
0 |
0 |
0 |